Fluoro AChE
- Known as:
- Fluoro AChE
- Catalog number:
- AChE100-3
- Product Quantity:
- 500 tests
- Category:
- -
- Supplier:
- Celleng-tech
- Gene target:
- Fluoro AChE
Ask about this productRelated genes to: Fluoro AChE
- Gene:
- ACHE NIH gene
- Name:
- acetylcholinesterase (Cartwright blood group)
- Previous symbol:
- YT
- Synonyms:
- -
- Chromosome:
- 7q22.1
- Locus Type:
- gene with protein product
- Date approved:
- 1989-06-02
- Date modifiied:
- 2019-04-23
Related products to: Fluoro AChE
(+)-5-Fluoro-2'-deoxyuridine (+)-5-Fluoro-2'-deoxyuridine For research use only.(-)-β-D-Dioxolane-5-fluoro Cytidine C8H10FN3O4 CAS: 145397-26-8(-)-β-D-Dioxolane-5-fluoro Cytidine CAS: 145397-26-8 Formula: C8H10FN3O4(11β)-21-Chloro-9-fluoro-11-hydroxy-16-methylpregna-1,4,16-triene-3,20-dione C22H26ClFO3 CAS: 1356190-17-4(11β)-21-Chloro-9-fluoro-11-hydroxy-16-methylpregna-1,4,16-triene-3,20-dione CAS: 1356190-17-4 Formula: C22H26ClFO3(11β,16α)-21-(Acetyloxy)-9-fluoro-11,16,17-trihydroxy-pregna-1,4,14-triene-3,20-dione C23H27FO7 CAS: 131918-74-6(11β,16α)-21-(Acetyloxy)-9-fluoro-11,16,17-trihydroxy-pregna-1,4,14-triene-3,20-dione CAS: 131918-74-6 Formula: C23H27FO7(11β,16α)-9-Fluoro-11,16,17,21-tetrahydroxy-pregna-1,4-diene-3,20-dione-d2 3,20-Dioxime C21H27D2FN2O6 CAS:(11β,16α)-9-Fluoro-11,16,17,21-tetrahydroxy-pregna-1,4-diene-3,20-dione-d2 3,20-Dioxime CAS: Formula: C21H27D2FN2O6(11β,16α)-9-Fluoro-11,21,21-trihydroxy-16,17-[(1-methylethylidene)bis(oxy)]
pregna-1,4-diene-3,20-dione CAS: 161740-69-8 Formula: C24H31FO7(11β,16α)-9-Fluoro-16,17,21-trihydroxyl-pregna-1,4-diene-3,11,20-trione 3,20-Dioxime C21H27FN2O6 CAS:(11β,16α)-9-Fluoro-16,17,21-trihydroxyl-pregna-1,4-diene-3,11,20-trione 3,20-Dioxime CAS: Formula: C21H27FN2O6(11β,16α,20R)-9-Fluoro-11,20-dihydroxy-16-methyl-3-oxopregna-1,4-dien-21-oic Acid C22H29FO5 CAS: 50764-01-7(11β,16α,20R)-9-Fluoro-11,20-dihydroxy-16-methyl-3-oxopregna-1,4-dien-21-oic Acid CAS: 50764-01-7 Formula: C22H29FO5(11β,16α,20S)-9-Fluoro-11,20-dihydroxy-16-methyl-3-oxopregna-1,4-dien-21-oic Acid C22H29FO5 CAS: 50764-02-8 Related articles to: Fluoro AChE
- To review extant literature for the use of digital technology to deliver cognitive training perioperatively to prevent or mitigate postoperative delirium (POD). Increasing rates of surgical care place pressures on healthcare systems. POD is a prevalent complication in older adults, worsening patient outcomes and up to 40% may be preventable. Since preoperative cognitive dysfunction is a primary risk factor, understanding the impact of technology-assisted cognitive enhancement on POD may improve patient experience and alleviate costs. Five databases were searched, and articles were reviewed by two investigators. Clinical trials that used digital technology perioperatively to prevent POD in older adults and written in English or French were included in the study. Relevant information was extracted. Out of the 630 articles identified, six ( = 6) were included. Surgical type, targeted cognitive domains and intervention dosing varied, exclusion criteria were restrictive and effectiveness was both positive and null. Relatively few relevant studies were identified indicating the literature is in its infancy. While two of the studies showed positive outcome trends, further research is needed to address adherence, modifiability of cognitive training programs, intervention dosage and less restrictive sampling. - Source: PubMed
Publication date: 2026/06/06
Johnson HilaryMonnin CarolinePatel RonakChoukou Mohamed-AmineEl-Gabalawy Renée - Modified radical mastectomy (MRM) is frequently associated with moderate to severe postoperative pain, which may negatively affect recovery and quality of life. Regional anesthesia techniques such as the erector spinae plane block (ESPB), thoracic paravertebral block (TPVB), and pectoral nerve block (PECS) have been increasingly used as part of multimodal analgesia strategies for breast surgery. However, their comparative effects on analgesic efficacy and quality of recovery remain unclear. - Source: PubMed
Publication date: 2026/06/06
Bezen Bilal AtillaAy MerveKaynak AliAkici MuratSivaci Remziye - Pulmonary lymphangitic carcinomatosis(PLC) is a life-threatening complication of intrathoracic malignant tumors and is characterized by tumor cell spread via the pulmonary lymphatic system.The lymphatic vessel dilation, interstitial thickening and edema caused by the tumor can lead to progressive breathing difficulties, which is a typical clinical feature of this condition.Pleuritic pain may occur if subpleural lymphatics are obstructed, but clinical manifestations are often non-specific.Most patients are diagnosed at an advanced stage with respiratory failure, and there is no definitive therapy; thus, the overall prognosis remains poor with short survival.Herein, we report a case of advanced cavitary lung adenocarcinoma complicated with PLC, with pericardial effusion and mediastinal or pericardial metastases.The patient underwent palliative surgery followed by sequential chemotherapy and immunotherapy and had survived for 41 months as of the last follow-up. - Source: PubMed
Publication date: 2026/06/06
Tang HuizhenZhou JiayiTian TianningGuan HaolinYe LiangYe Liang - Trigger finger (stenosing tenosynovitis) reflects abnormal tendon-pulley mechanics, primarily at the A1 pulley; however, objective assessment during functional motion remains limited in routine clinical practice. We evaluated electrical contact resistance (ECR) from a wearable tactile sensor during standardized digit motion and examined its association with symptoms. - Source: PubMed
Publication date: 2026/06/06
Huang Jhih-FongKarmakar Rajat SubhraLin Yu-ChunChao Jui-ILu Yen-Wen - While current surgical approaches for obstructed defecation syndrome (ODS) primarily target rectocele and rectal intussusception, excessive perineal descent (PD) may contribute to persistent symptoms and suboptimal surgical outcomes. This study aimed to evaluate early outcomes of transverse perineal support (TPS), a procedure designed to reinforce the perineum, in patients with ODS and pathological PD. - Source: PubMed
Publication date: 2026/06/06
Azmy Basiouny Haitham MShafik Ali AhmedElbarmelgi Mohamed YehiaRefaie OsamaTamer MohamedAlwafa Mahmoud Adel AbuAbdelaal Ahmed Mohamed